ProceduralSurgical principlesOPCS Y82

Local anaesthesia in skin surgery

LA ยท infiltration anaesthesia ยท regional / field block ยท ring block

Local anaesthesia is the cornerstone of skin-oncology surgery. Lidocaine (commonest), bupivacaine (long-acting), prilocaine and levobupivacaine are common agents; vasoconstrictors are used where appropriate to reduce bleeding and systemic absorption. Safe practice requires understanding of maximum doses, onset / duration, technique selection (infiltration, ring block, field block, regional block), adrenaline contraindications and toxicity recognition. Association of Anaesthetists LAST guidance and BSDS surgical-practice materials underpin good practice.

CurrentLast reviewed 7 June 2026

Agents

AgentOnsetDuration plainDuration with vasoconstrictorMax dose plainMax dose with vasoconstrictor
Lidocaine 1-2%2-5 min30-60 min2-6 h3 mg/kg (max 200 mg)7 mg/kg (max 500 mg)
Bupivacaine 0.25-0.5%10-15 min4-8 h8-16 h2 mg/kg (max 150 mg)Do not routinely increase above plain maximum; follow current BNF / SmPC / local policy.
Prilocaine 1-2%3-5 min30-90 min3-8 h with felypressin6 mg/kg (max 400 mg)With felypressin: 8 mg/kg (max 600 mg).
Levobupivacaine 0.25-0.5%10-15 min3-6 hVariable2 mg/kg (max 150 mg)No routine dose increase; follow current BNF / SmPC / local policy.

Quick conversion: 1% solution = 10 mg/mL. So 20 mL of lidocaine 1% = 200 mg (โ‰ˆ max plain dose for a 70 kg adult).

These are typical adult maximum-dose guardrails used in UK skin surgery; always use the current BNF / SmPC, local policy and the lower safer dose in frail, elderly, low-body-weight, pregnant, hepatic / renal impairment or highly vascular-site cases. Toxicity is additive if local anaesthetics are mixed.

Adrenaline (epinephrine): typically 1:100 000 (10 ยตg/mL) or 1:200 000 (5 ยตg/mL). Onset 3-5 min for vasoconstriction; reduces bleeding and prolongs anaesthesia.

Technique

  • Infiltration: subcutaneous injection in plane of intended excision; aspirate before injection to avoid intravascular.
  • Field block: peripheral ring of injections encircling the lesion; useful for larger lesions and where direct infiltration distorts anatomy (e.g. eyelid, nasal tip).
  • Ring block: digital nerve block at base of finger / toe; avoid adrenaline historically; modern evidence supports adrenaline safe in healthy digits.
  • Regional / nerve block: supraorbital, infraorbital, mental, great auricular, transcutaneous mental.
  • Tumescent: large-volume dilute lidocaine + adrenaline (separate monograph).
  • Tips to reduce pain of injection:
    • Warm solution to body temperature.
    • Buffer with 8.4% sodium bicarbonate 1:10 ratio (raises pH; reduces sting).
    • Use fine 27-30G needle; slow injection.
    • Distraction; counter-pressure.

Adrenaline considerations

  • Benefits: vasoconstriction (less bleeding, better field), prolongs anaesthesia, reduces systemic absorption (allowing higher max LA dose).
  • Cautions:
    • Severe cardiovascular disease (uncontrolled hypertension, recent MI, unstable arrhythmia) โ€” discuss with cardiology.
    • Phaeochromocytoma โ€” avoid.
    • MAOI / TCA: limit dose due to potentiation.
    • Avoid in cocaine intoxication.
  • End-arteries / appendage debate: historical avoidance in digits, nose tip, earlobe, penis. Modern evidence (Denkler 2001; Lalonde Dalhousie series) supports safety with 1:100 000 in healthy digital surgery; rebound vasodilatation possible. Use with care in patients with peripheral vascular disease, Raynaud, smokers.

Local anaesthetic systemic toxicity (LAST)

  • Caused by inadvertent intravascular injection or absolute / relative overdose.
  • Risk factors: high total dose, vascular sites, infiltration of inflamed / vascularised tissue, hepatic / renal impairment, pregnancy, neonates, elderly.
  • Early symptoms (CNS): perioral tingling, metallic taste, tinnitus, light-headedness, dysarthria, visual disturbance, agitation.
  • Late symptoms (CNS): tonic-clonic seizures, coma.
  • Cardiovascular: hypotension, bradycardia, ventricular arrhythmias, cardiac arrest โ€” bupivacaine particularly cardiotoxic.
  • Management:
    • Stop injection; airway / breathing / circulation; 100% O2.
    • Treat seizures: benzodiazepine.
    • Cardiac arrest: ALS algorithm; avoid lidocaine (already toxic) and vasopressin.
    • Lipid emulsion 20% (Intralipid) 1.5 mL/kg bolus then 0.25 mL/kg/min infusion โ€” AAGBI / ASRA guideline.
  • Every clinic that uses LA should have Intralipid and AAGBI LAST algorithm immediately available.

Practical points

  • Document agent, concentration, volume, total milligrams given, and time.
  • Calculate maximum dose per kg before drawing up.
  • Allow full onset before incision: lidocaine 2-5 min plain, 5-10 min with adrenaline for full vasoconstriction.
  • Avoid mixing local anaesthetics in routine practice (additive toxicity).
  • Confirm patient has not eaten heavily if planning IV sedation.
  • For paediatric / anxious patients: topical EMLA / tetracaine pre-needle.
  • Pregnancy: lidocaine is commonly used when local anaesthesia is required; use the lowest effective dose and seek obstetric / anaesthetic advice for complex or high-volume cases.

References

  1. Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012;59:90-102.
  2. Association of Anaesthetists. Management of severe local anaesthetic toxicity 2023. London: Association of Anaesthetists; 2023.
  3. Denkler K. A comprehensive review of epinephrine in the finger: to do or not to do. Plast Reconstr Surg. 2001;108:114-124.
  4. British Society for Dermatological Surgery. Annual Surgery Workshop Manual. London: BSDS; 2024.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.